11 Feb 2026 intraday: 5585.T stock JPY 2184.00 shows oversold bounce

The 5585.T stock is trading at JPY 2184.00 intraday on 11 Feb 2026, showing an early oversold bounce after recent profit-taking. Volume is light at 3,300.00 shares versus a 50-day average of 41,287.00, yet price sits just below the year high of JPY 2247.00, signalling a short-term mean reversion opportunity. Investors watching healthcare DX names should weigh the high valuation — PE 58.47 — against strong balance-sheet metrics and stable earnings per share of JPY 37.35.

Price action and intraday setup for 5585.T stock

The immediate fact is the intraday price of JPY 2184.00 with a day range of JPY 2184.00–2190.00. This narrow range and low relative volume suggest a quiet oversold bounce rather than a momentum breakout.

Traders looking for a tactical entry should watch Keltner channel support near JPY 2172.00 and the 50-day average at JPY 2184.38. A move back above JPY 2196.00 (upper Keltner) would confirm strength for a short-term swing.

Fundamentals and valuation context for 5585.T stock

EcoNaviSta, Inc. (5585.T) shows a conservative balance sheet with cash per share JPY 427.24 and no net debt, supporting resilience in Healthcare DX services. Gross margin is strong at 71.16%, and net margin is 25.94%, reflecting recurring software and monitoring revenue.

Valuation is rich: price-to-earnings near 57.08 and price-to-sales 15.57. That premium prices growth and technology IP; investors should compare these ratios to the Japan Healthcare sector average PE 24.33 when sizing positions.

Technical indicators and the oversold bounce strategy for 5585.T stock

Technicals show a short-term oversold bounce setup: ATR is 6.00, Keltner support at JPY 2172.00, and the stock is trading near its 50-day average. Low relative volume (relVolume 0.08) indicates limited participation so far, making risk management essential.

For an oversold bounce strategy, set a tight stop below JPY 2172.00 and scale out near JPY 2247.00 (year high). A break under JPY 2170.00 invalidates the bounce and favours a wait-and-see approach.

Meyka AI rating and analyst context for 5585.T stock

Meyka AI rates 5585.T with a score out of 100: 72.24 (B+) — BUY. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus.

The company rating file shows mixed signals: DCF analysis flags upside while PE-based measures rate the stock expensive. Use the Meyka grade as one input; it is not financial advice.

Catalysts, risks, and sector comparison for 5585.T stock

Catalysts include ongoing adoption of Liferhythmavi + Dr. and new monitoring contracts in the nursing care market. Revenue growth last fiscal year was 24.42%, and net income growth was 22.47%, supporting a growth story.

Risks include high valuation (PE 57.08), low trading liquidity (avg volume 41,287.00), and concentration in Japan’s nursing care DX market. Compare sector avg PE 24.33 and avg current ratio 3.07 to gauge relative value and balance-sheet strength.

Short-term trading plan and price targets for 5585.T stock

For traders using the oversold bounce approach, consider a staged buy between JPY 2175.00 and JPY 2188.00, initial stop at JPY 2168.00, and partial target at JPY 2247.00. A conservative price target from technical resistance is JPY 2247.00, and failure below JPY 2168.00 triggers exit.

Analyst-style price targets: conservative JPY 2,500.00, base JPY 3,000.00, and downside scenario JPY 2,000.00. Adjust sizing for low liquidity and the stock’s premium multiples.

Final Thoughts

Short-term, the 5585.T stock shows an intraday oversold bounce at JPY 2184.00 with limited volume. The setup fits a tactical mean-reversion trade: enter near the 50-day average and use Keltner support at JPY 2172.00 for stops. Fundamental strength is real — cash per share JPY 427.24, EPS JPY 37.35, and strong margins — but valuation is elevated with PE 57.08, so treat positions as tactical rather than core.

Meyka AI’s forecast model projects a base target of JPY 2,500.00 (implied upside 14.47% vs current JPY 2184.00), a bull case of JPY 3,000.00 (implied upside 37.38%), and a bear case of JPY 2,000.00 (implied downside -8.42%). Forecasts are model-based projections and not guarantees. Use tight risk controls, monitor daily volume, and compare the stock’s premium multiples against Japan’s Healthcare sector before adding exposure. For real-time monitoring and additional signals, see Meyka AI’s platform and the issuer’s site.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.